The legacy of Viagra and its creator , copyright, presents a fascinating picture for cautious investors. While the revolutionary drug initially produced enormous profits , its patent has expired , leading to rival alternatives flooding the landscape . This erosion in cost presents a substantial hurdle for copyright and any company considering a sig